🇮🇳IN
Sign In
SU

SUPRIYA

NSE

Supriya Lifescience Ltd

₹818.55

-17.70(-2.12%)
FSI

Fundamental Strength Index

computed from the statements below↑ higher is better

Weights come from configuration, not from this page — each pillar links to the section below that explains it.

Income stmtHistory

Profitability

headline ratios

Growth

compounded, from filed annual results

Segment Results

₹ Cr

Working Capital & Efficiency

days · ROCE %

SUPRIYA financial summary

For Mar 2026, Supriya Lifescience Ltd reported revenue of ₹828 crore, which grew 19.0% from the previous year. Net profit was ₹209 crore, which grew 11.2% year on year, on an operating margin of 36%. Earnings per share came in at ₹25.98. Annual results are available for 10 financial years, from Mar 2017 to Mar 2026.

Revenue₹828 crore
Net profit₹209 crore
Operating margin36%
EPS₹25.98

Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Disclaimer